Albert Farrugia

2.4k total citations
112 papers, 1.5k citations indexed

About

Albert Farrugia is a scholar working on Hematology, Management of Technology and Innovation and Biochemistry. According to data from OpenAlex, Albert Farrugia has authored 112 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Hematology, 34 papers in Management of Technology and Innovation and 27 papers in Biochemistry. Recurrent topics in Albert Farrugia's work include Hemophilia Treatment and Research (39 papers), Blood donation and transfusion practices (34 papers) and Blood transfusion and management (27 papers). Albert Farrugia is often cited by papers focused on Hemophilia Treatment and Research (39 papers), Blood donation and transfusion practices (34 papers) and Blood transfusion and management (27 papers). Albert Farrugia collaborates with scholars based in Australia, United States and Italy. Albert Farrugia's co-authors include Clive R. Seed, Jeffrey S. Stonebraker, J. Dawes, C V Prowse, Alok Srivastava, Mark Brooker, Isabella Quinti, Shannon L. Farmer, Sherri Ozawa and Aryeh Shander and has published in prestigious journals such as Blood, Frontiers in Immunology and Journal of Pharmaceutical Sciences.

In The Last Decade

Albert Farrugia

107 papers receiving 1.4k citations

Peers

Albert Farrugia
Edwin Massey United Kingdom
Rainer Seitz Germany
Alyssa Ziman United States
Benjamin Lichtiger United States
W. H. Churchill United States
Gilles Folléa France
M. F. Murphy United Kingdom
Hans Erik Heier Norway
Marcela Contreras United Kingdom
Derwood Pamphilon United Kingdom
Edwin Massey United Kingdom
Albert Farrugia
Citations per year, relative to Albert Farrugia Albert Farrugia (= 1×) peers Edwin Massey

Countries citing papers authored by Albert Farrugia

Since Specialization
Citations

This map shows the geographic impact of Albert Farrugia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Farrugia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Farrugia more than expected).

Fields of papers citing papers by Albert Farrugia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Albert Farrugia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Farrugia. The network helps show where Albert Farrugia may publish in the future.

Co-authorship network of co-authors of Albert Farrugia

This figure shows the co-authorship network connecting the top 25 collaborators of Albert Farrugia. A scholar is included among the top collaborators of Albert Farrugia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Albert Farrugia. Albert Farrugia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Farrugia, Albert, et al.. (2025). The past, present and future of blood plasma fractionation. Biologicals. 91. 101849–101849.
2.
Farrugia, Albert. (2023). The World Health Organisation's list of essential medicines and haemophilia treatment products. Haemophilia. 29(6). 1387–1389. 1 indexed citations
3.
Farrugia, Albert, Megha Bansal, & Ivan Marjanović. (2021). Estimation of the latent therapeutic demand for immunoglobulin therapies in autoimmune neuropathies in the United States. Vox Sanguinis. 117(2). 208–219. 3 indexed citations
4.
Focosi, Daniele & Albert Farrugia. (2020). The art of the possible in approaching efficacy trials for COVID19 convalescent plasma. International Journal of Infectious Diseases. 102. 244–246. 8 indexed citations
5.
Farrugia, Albert. (2020). Plasma from donors convalescent from SARS-CoV-2 infection–A matter of priorities. Transfusion Clinique et Biologique. 27(3). 167–168. 5 indexed citations
6.
Focosi, Daniele & Albert Farrugia. (2020). Urgent Need to Regulate Convalescent Plasma Differently from Thawed Plasma. Transfusion Medicine and Hemotherapy. 48(2). 132–133. 5 indexed citations
7.
Farrugia, Albert, et al.. (2015). Issues in assessing products for the treatment of hemophilia – the intersection between efficacy, economics, and ethics. Journal of Blood Medicine. 6. 185–185. 6 indexed citations
8.
Farrugia, Albert & Eleftherios C. Vamvakas. (2014). Toward a patient-based paradigm for blood transfusion. Journal of Blood Medicine. 5. 5–5. 8 indexed citations
9.
Stonebraker, Jeffrey S., et al.. (2013). Modeling Primary Immunodeficiency Disease Epidemiology and Its Treatment to Estimate Latent Therapeutic Demand for Immunoglobulin. Journal of Clinical Immunology. 34(2). 233–244. 19 indexed citations
10.
Farrugia, Albert, et al.. (2009). Plasma fractionation issues. Biologicals. 37(2). 88–93. 32 indexed citations
11.
Yao, Felix, Clive R. Seed, Albert Farrugia, et al.. (2008). Comparison of the risk of viral infection between the living and nonliving musculoskeletal tissue donors in Australia. Transplant International. 21(10). 936–941. 8 indexed citations
12.
Farrugia, Albert. (2006). When do tissues and cells become products? – Regulatory oversight of emerging biological therapies. Cell and Tissue Banking. 7(4). 325–335. 12 indexed citations
13.
Farrugia, Albert, James W. Ironside, & Paul Giangrande. (2005). Variant Creutzfeldt–Jakob disease transmission by plasma products: assessing and communicating risk in an era of scientific uncertainty. Vox Sanguinis. 89(4). 186–192. 18 indexed citations
14.
Farrugia, Albert, Catherine S. Manno, & Bruce L. Evatt. (2004). Emerging and receding risks of therapeutic regimens for haemophilia. Haemophilia. 10(s4). 47–54. 6 indexed citations
15.
Farrugia, Albert. (2004). Safety and supply of haemophilia products: worldwide perspectives. Haemophilia. 10(4). 327–333. 16 indexed citations
16.
Ramasamy, Indra, et al.. (2000). Flow–Cytometric Method for the Quantitation of the Fc Function of Intravenous Immunoglobulin Preparations. Vox Sanguinis. 78(3). 185–193. 5 indexed citations
17.
18.
19.
Farrugia, Albert, et al.. (1992). Factor VIII/von willebrand factor levels in plasma frozen to - 30 ° C in air or halogenated hydrocarbons. Thrombosis Research. 68(1). 97–102. 8 indexed citations
20.
Farrugia, Albert, et al.. (1989). A microtitre plate test for assesment of in-vitro thrombogenicity in factor IX concentrates using a chromogenic substrate. Thrombosis Research. 53(2). 191–196. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Edwin Massey Breakdown of academic impact, for papers by Rainer Seitz Breakdown of academic impact, for papers by Alyssa Ziman Breakdown of academic impact, for papers by Benjamin Lichtiger Breakdown of academic impact, for papers by W. H. Churchill Breakdown of academic impact, for papers by Gilles Folléa Breakdown of academic impact, for papers by M. F. Murphy Breakdown of academic impact, for papers by Hans Erik Heier Breakdown of academic impact, for papers by Marcela Contreras Breakdown of academic impact, for papers by Derwood Pamphilon
Rankless by CCL
2026